Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

iDose® TR marks a significant breakthrough in the treatment of glaucoma, offering a consistent and reliable option for managing intraocular pressure (IOP). Differing from traditional eye drops that need to be applied every day, iDose® TR is a compact, implantable device engineered to release a controlled release of medication directly into the eye over an longer period. This groundbreaking approach removes the hassle of daily applications, dramatically boosting patient adherence and overall treatment outcomes.

At Eye Center South, we are excited to provide iDose® TR as part of our all-encompassing glaucoma care. The device is implanted during a minimally invasive procedure, focused on your comfort and ease. Once in place, it provides a steady dose of the prescribed medication, helping to maintain stable IOP levels and protect your vision. Patients who have difficulty managing the challenges of daily eye drop regimens can benefit greatly from this next-generation treatment.

Visit for more info At Eye Center South